Lactobacillus iners
Selected indexed studies
- Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. (Cancer Cell, 2023) [PMID:37863066]
- Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review. (Front Cell Infect Microbiol, 2021) [PMID:34881196]
- Lactobacillus iners-dominated vaginal microbiota in pregnancy. (Ceska Gynekol, 2019) [PMID:31948257]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. (2022) pubmed
- Vaginal Lactobacillus fatty acid response mechanisms reveal a metabolite-targeted strategy for bacterial vaginosis treatment. (2024) pubmed
- Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. (2023) pubmed
- Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review. (2021) pubmed
- Lactobacillus iners-dominated vaginal microbiota in pregnancy. (2019) pubmed
- Lactobacillus iners: Friend or Foe? (2017) pubmed
- Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. (2020) pubmed
- A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. (2020) pubmed
- Vaginal microbiome of reproductive-age women. (2011) pubmed
- Lactobacillus iners, the unusual suspect. (2017) pubmed